PICO Portalanswers from OpenAlex & ORCID
Mary J. Fidler
ResearcherPublications, citations & collaboration network
Mary J. Fidler is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Mary J. Fidler have?
PICO Portalindexed works
Mary J. Fidler has 228 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mary J. Fidler have?
PICO Portalcitation count
Mary J. Fidler has 11,016 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Mary J. Fidler?
PICO Portalh-index
Mary J. Fidler has an h-index of 27 in OpenAlex.
What is the i10-index of Mary J. Fidler?
PICO Portali10-index
Mary J. Fidler has an i10-index of 60 in OpenAlex.
What is the ORCID of Mary J. Fidler?
PICO Portalorcid
The ORCID for Mary J. Fidler is on the source record.
What is the OpenAlex record for Mary J. Fidler?
PICO Portalopenalex
The OpenAlex for Mary J. Fidler is on the source record.
What are the most-cited papers on Mary J. Fidler?
PICO Portalmost cited works
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung‐Ju Ahn, Ainara Soria, Jean‐Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan D. Cheng, Ramona F. Swaby, Kevin J. Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Myung‐Ju Ahn, Mario Airoldi, Eduardas Aleknavičius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra E.W. Cohen, Tibor Csőszi, Jan Paul de Boer, Jean‐Pierre Delord, Andreas Dietz, José Dinis, Charlotte Dupuis, Laurence Digue, József Erfán, Yolanda Escobar Alvarez, Mererid Evans, Mary J. Fidler, Martin Förster, Signe Friesland, Apar Kishor Ganti, Lionnel Geoffrois, Clíona Grant, Viktor Gruenwald, Kevin J. Harrington, Thomas K. Hoffmann, Geza Horvai, Arturas Inčiūra, Raymond Woo-Jun Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juárez Ramiro, Bogusława Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung‐Bae Kim, Judit Kocsis, Nuria Kotecki, Mark Kozloff, J. Lambea, László Landherr, Yuri Lantsukhay, Sergey Lazarev, Lip Way Lee, Christophe Le Tourneau, Lisa Licitra, Igor Lifirenko, Nicolas Mach, Danko Martincic, О. В. Маторин, Margaret McGrath, Jean‐Pascal Machiels, Ranee Mehra, Krzysztof Misiukiewicz, John C. Morris, Ф. Ф. Муфазалов, Jiaxin Niu, Devraj Srinivasan, Pedro Pérez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina P. Rodriguez, Frédéric Rolland, Antonio Russo, Ágnes Ruzsa, Frederico Sanches, Sangwon Shin, Mikhail Shtiveland
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer
Anthony W. Kim, Marta Batus, Ronald Myint, Mary J. Fidler, Sanjib Basu, Philip Bonomi, L. Penfield Faber, Sean C. Wightman, William H. Warren, Maria McIntire, Leonidas Arvanitis, Paolo Gattuso, Xiulong Xu, Michael J. Liptay